Esophageal small cell cancer

Clinical case report and literature review

Authors

  • Robinson Rodríguez Servicio de Hematología Especializada, Hospital Central de las Fuerzas Armadas https://orcid.org/0000-0001-8495-8934
  • Susana González Servicio de Hematología Especializada, Hospital Central de las Fuerzas Armadas
  • Matilde Gericke Servicio de Hematología Especializada, Hospital Central de las Fuerzas Armadas
  • Carlos Garbino Servicio de Hematología Especializada, Hospital Central de las Fuerzas Armadas

DOI:

https://doi.org/10.35954/SM1998.20.1.5

Keywords:

Esophageal neoplasia, small cell tumours, chemotherapy

Abstract

Small cell esophageal carcinoma is an uncommon entity. Until now no more than 150 cases have been reported. This neoplasia is part of the neuroendocrine carcinomas. Is a very agressive cancer and 70% of the cases is a disseminated tumour at the moment of the initial diagnosis. These tumours are sensitive to radiation therapy and chemotherapy. Mean survival of metastatic disease is less than five months.
A female patient, 61 years old with a small cell esophageal carcinoma is reported. Dysphagia was the presenting symptom. Polychemothererapy with CODE (cisplatin- vincristine-adryamicin-etoposide) was utilized and a complete remission was obtained. A literature review was performed.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

(1) VASALLO JA. Cáncer en el Uruguay. Registro Nacional del Cáncer del Uruguay, 1ª Edición 1989: 51-59.

(2) DE VITTA VT, HELLMAN S, ROSENBERG SA. Cáncer. Principios y Práctica de Oncología. 2ª Edición. Barcelona, Salvat 1987, V. I: 582-611.

(3) IBRAHIM NBN, BRIGGS JC, CORBISHLEY CM. Extrapulmonary oat cell carcinoma. Cancer 1984; 54: 1645-1661.

(4) MC KEOWN F. Oat cell carcinoma of the esophagus. J Pathol Bacteriol 1942; 64: 889-891.

(5) MC FADDEN DW, RUDNICKI M, TALAMI MA. Primary small cell carcinoma of the esophagus. Ann Thorac Surg 1989; 47: 477-480.

(6) LIU YH. Chung-Hua-Chung-Liu-Tsa. Chih 1991; 13 (2): 123-125.

(7) MULDER LD, GARDINER GA, WEEKS DA. Primary Small Cell Carcinoma of the Esophagus: Case Presentation and review of the Literature. Gastrointest Radiol 1991; 16: 5-10.

(8) TENNVALL J, JOHANSSON L, ALBERTSSON M. Small cell carcinoma of the esophagus: a clinical and inmunohistopahological review. European J Surg Oncol 1990; 16: 109-115.

(9) PROCTOR DD, FRASER JL, MANGANO MM, ROSENBERG SJ. Small cell carcinoma of the esophagus in a patient with Longstanding Primary Achalasia. American J Gastroenterol 1992; 87: 664-667.

(10) HO KJ, HERRERA GA, JONES JM. Small Cell Carcinoma of the Esophagus: evidence for a unified histogenesis. Hum Pathol 1984; 15: 468- 480.

(11) OLMSTED WW, LICHTENSTEIN JE, HYAMS VJ. Polipoid epithelial malignancies of the esophagus. Am J Radiol 1983; 140: 921-925.

(12) MATSUSAKA T, WATANABE H. Anaplastic carcinoma of esophagus: Report of three cases and their histogenetic consideration. Cancer 1976; 37: 1352-1358.

(13) KARNAD A, POSKITT TR. Small cell carcinoma of the esophagus. J Tenn Med Assoc 1984; 84: 451.

(14) TANABE G, KAJISA T, SHIMAZU HH. Effective chemotherapy for small cell carcinoma of the esophagus. Cancer 1987; 60: 2613.

(15) DOHERTY MA, MC INTYRE M, ARNOTT SJ. Oat cell carcinoma of the esophagus: A report of six British patients with a review of the Literature. J. Radiot Oncol Biol Phys 1984; 10: 147-152.

(16) BENSCH KG, CORRIN B, PARIENTE R, SPENCER H. Oat cell carcinoma of lung. Cancer 1968; 22: 1163-1172.

(17) WORLD HEALTH ORGANITATION. Histological typing of lung tumours.2nd. de. Ann J Clin Pathol1982; 77:123-136.

(18) TATEISHI R, TANIGUCHI K, HORAI T. Argyrophil cell carcinoma (Apudoma) of the esophagus. Virchows Arch (A) 1976; 371: 283-294.

(19) GOUL VE, LINOILA L, MEMOLI VA. Biology of disease. Neuroendocrine components of the broncho-pulmonary tract: Hiperplasia, dysplasia and neoplasms. Lab Invest 1983; 49: 519-537.

(20) TENNVALL J, BIORKLUND A, JOHANSSON L, AKERMAN M. Merkel cell carcinoma. Menagement of primary recurrent and metastasic disease. A clinicopathological study of 17 patients. Eur J Surg Oncol 1989; 15: 1-9.

(21) RIVERA F, MATILLA A, FERANDEZ SANZ J, GALERA H. Oat cell carcinoma of the esophagus. Case description and review of the literature. Virchows Arch A (Pathol Anat) 1981; 391: 337-344.

(22) REYES CV, CHEJFEC G, WELLINGTON J, GOULD VE. Neuroendocrine carcinoma of the esophagus. Ultrastructural Pathol 1980;1:367-376.

(23) BRIGGS JC, IBRAHIM NB. Oat cell carcinoma of the esophagus: A clinico-pathological study of 23 cases. Histophatology 1983; 7: 261-277.

(24) JOHNSON FE, CLAUSON MC, BASHITI HM. Small cell undifferentiated carcinoma of the esophagus. Case report with hormonal studies. Cancer 1984; 53: 1746-1751.

(25) PEARSE AGE. The cytochemestry and ultrastructure of polypeptide hormone producing cells of the A.P.U.D. series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 1969; 17: 303.

(26) WIRK MARK R. Neuroendocrine Neoplasia: An overview of current concept and terminology. American Society of Clinical Oncology, 30th. Annual Meeting. Educational Book 1994; 246-248.

(27) TETU B, RO JY, AYALA AG, JONSON DE. Small cell carcinoma of the prostate. Part 1. A clinicopathology study of 20 cases. Cancer 1987; 59: 1803-1809.

(28) SABARTANAM S, GRAHAM GP, DALAES FD. Primary oat cell carcinoma of the esophagus. Thorax 1986; 41: 318-321.

(29) KELSEN DP, WESTON E, KURTZ R. Small cell carcinoma of the esophagus: Treatment by chemotherapy alone. Cancer 1980;45: 1558-1561.

(30) LEVENSON RM, IHDE DC, MATHEWS MJ. Small cell carcinoma presenting as an extrapulmonary neoplasm: Sites of origin and response to chemotherapy. J Nat Cancer Inst 1981; 67: 607.

(31) GONZÁLEZ S, VARANGOT M, ARDAO G, VIOLA A. Cáncer de Esófago a células pequeñas. A propósito de tres casos. Congreso Argentino de Oncología, 11, 1993. Tumor 1993; 6 (4): 115.

(32) RODRÍGUEZ R, GONZÁLEZ S, GERICKE M. Carcinomas Neuroendócrinos. Presentación y evolución de 20 casos. Congreso Uruguayo de Oncología, 3, 1994. Archivos de Medicina Interna. Separata III Congreso Uruguayo de Oncología 1994; 10 (Res. 34). Uruguay.

(33) OSOBE D, SHAL A, MURRAY N, GRAFTON C, KARSAIN H. Improved survival in extensive stage small cell lung cancer on CODE chemotherapy. Proc Am Soc Clin Oncol 1990; 9: 868 (Abstract).

(34) MASUDA N, FUKUOKA M, FURUSE K. CODE chemotherapy with or without recombinant human granulocyte colony-stimulating factor in extensive stage small cell cancer. Oncology 1992; 49 (Suppl. 1): 19-24.

(35) GARBINO C. Consideraciones sobre el tratamiento del cáncer de pulmón a pequeñas células. En Temas Prácticos de Medicina Interna. De. Dante Tomalino. Edtorial Librería Médica S.R.L. 1995. Montevideo. Vol. 9: 301-311.

(36) METCALF D, MORTSTYN. Colony stimulating factors: general biology. En Biologic therapy of cancer. De Vita VT Jr., Hellman S, Rosenberg SA, editores. JB Lippincott. Philadelphia USA 1991: 417-444.

(37) MAYORDOMO JI, RIVERA F, DIAZ PUENTE MT, LIANES MP, LÓPEZ BREA M. Decreasing morbidity and cost of treating febrile neutropenia by adding G-CSF and GM-CSF to standard antibiotic therapy: Results of a randomized trial. Proc Am Soc Clin Oncol 1993; 12 : 437 (Abstract 1510).

(38) TRILLET-LENOIR V, GREEN J, MANEGOL C, VON PAWELL J, GATZMEIER V. Recombinant granulocyte colony stimulating factor reduces the infections complications of cytotoxic chemothe- rapy. Eur J Cancer 29A, 1993: 319.

(39) AGHIETTA M, MONZEGLIO C, PASQUINO P, CARNINO F, STERM A. Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of citostatic drugs. Cancer 1993; 72: 2970.

(40) GARBINO C, CAZERES JC, RODRÍGUEZ R. Comparative analysis of neutropenia grade 3 and 4 treated with G-CSF and GM-CSF. Proc Am Soc Clin Oncol 1995; 14: 262 (Abstract 720).

Downloads

Published

1998-12-30

How to Cite

1.
Rodríguez R, González S, Gericke M, Garbino C. Esophageal small cell cancer: Clinical case report and literature review. Salud Mil [Internet]. 1998 Dec. 30 [cited 2026 Apr. 15];20(1):27-33. Available from: https://revistasaludmilitar.uy/ojs/index.php/Rsm/article/view/64

Issue

Vol. 20 No. 1 (1998)

Section

Original Articles

License

Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:

Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.

As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.

Under the following terms:

1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.

2. NonCommercial: you may not use the material for commercial purposes.

3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.

 

Crossref
Scopus
Google Scholar
Europe PMC

        PlumX Metrics

Most read articles by the same author(s)